Publications by authors named "M R Litzow"

Claim this Profile
E
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141).
Robert Jeraj, Fenghai Duan, Ryan J Mattison, Justin Romanoff, Lale Kostakoglu, Mark R Litzow

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blast Clearance Dynamics and Time to Response Across and -Mutated AML.
Mohamad Sheikh Najeeb, Oudai Alkabbani, Rong He, Dragan Jevremovic, Patricia T Greipp, Mark R Litzow

EJHaem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RNA N-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signaling.
Yanhong Tan, Changli Zhou, Sicheng Bian, Huiqin Bian, Yanan Ren, Mark R Litzow

Cell Death Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia.
Rasha W Al-Ali, Gege Gui, Niveditha Ravindra, Georgia Andrew, Devdeep Mukherjee, Mark R Litzow

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL.
Daniela R Anderson, Radhika Gangaraju, Wafik G Sedhom, Eva N Hamulyák, Tzu-Fei Wang, Mark R Litzow

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis